OTS membership is open to all individuals from industry, academia and other institutions worldwide who are interested in research and development of oligonucleotide therapeutics (RNAi, CpG, antisense, ribozymes, and others).
As a member you benefit from:
• A network of experts covering all areas of nucleic-acid drug development (chemistry, physics, mechanisms, biology, model systems, clinical trials, market analysis, patent issues)
• The option of joint membership with ISN3A
To become a member of OTS, and subscribe to the society's journal "Oligonucleotides', click here.
The annual dues for 1 year are US $125 for regular members from faculty and industry, and US $75 for students. Membership includes a 1-year print and online subscription to the society's journal "Oligonucleotides". Your membership will become effective immediately upon receiving the application fee.
|
